You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Medtronic knows how committed you are to helping patients manage their health. We share your commitment with a passion for providing lifelong solutions that can assist you in managing patients' chronic medical conditions. Our products range from diagnostic equipment to therapies that manage long-term conditions where other medical therapies have failed.
In continuing to this website, you acknowledge you are a registered healthcare professional and I have a valid certification in your possession.
By clicking 'Accept' below you agree that you are a registered healthcare professional and you have a valid certification in your possession.
About the Therapy
DBS therapy for Parkinson’s uses a surgically implanted medical device to deliver electrical stimulation to precisely targeted areas within the brain. Just like a pacemaker for the heart, a small device is surgically placed under the skin in the chest to deliver DBS therapy. The device sends electrical pulses through the extension to the leads and electrodes that are placed in an area of the brain that controls movement. These pulses disrupt some of the brain’s messages that cause the symptoms associated with Parkinson’s disease.
DBS therapy is reversible and can be discontinued at any time by turning off or surgically removing the device. More
All treatment and outcome results are specific to the individual patient, and will form part of your consultation with your healthcare professional.
Please consult your healthcare professional for a full list of benefits, indications, precautions, clinical results, and other important medical information that pertains to DBS therapy.
Learn some of the commonly asked questions and concerns about how DBS therapy may reduce the symptoms of Parkinson's disease.
Deep brain stimulation (DBS) therapy is a surgical treatment which may reduce some of the symptoms associated with Parkinson's disease (PD).1
DBS uses a surgically implanted medical device similar to a cardiac pacemaker to deliver electrical stimulation to precisely targeted areas within the brain.
Stimulation of these areas blocks the signals that cause the disabling motor symptoms of Parkinson's disease. The electrical stimulation can be noninvasively adjusted to maximise therapy benefits. As a result, many individuals may achieve greater control over their body movements.
A DBS system consists of three implanted components:
Your surgeon may provide you with a small, handheld patient programmer or magnet. This programmer lets you turn the system on and off by holding it for 1 or 2 seconds against the area where the neurostimulator is implanted. However, in most cases, the neurostimulator is always on.
The DBS system consists of three implanted components:
The device settings and stimulation levels can be adjusted noninvasively by a clinician using a programming device.
Although there is no cure for Parkinson's disease, DBS may reduce some of the symptoms associated with Parkinson's disease.1
Risks of DBS can include risks of surgery, side effects, or device complications. Please see Benefits and Risks for more details.
Neurologists and neurosurgeons have used electrical stimulation since the 1960s as a way to locate and distinguish specific sites in the brain. Brain stimulation technology was developed in the 1980s.
Today, DBS therapy is performed in more than 1,000 hospitals around the world, with over 140,000 people worldwide, including more than 2,000 Australians are benefiting from it.2 DBS therapy has been used for the treatment of Parkinson's disease, Essential Tremor and Dystonia in Australia since 1994.
There is no cure for Parkinson's disease at this time. DBS therapy may reduce some of the symptoms of Parkinson's disease1, but does not cure the underlying condition. If the therapy is discontinued, your symptoms will return.
In the PD clinical study, 87% of patients demonstrated improved motor scores in the OFF medication state at the end of the 12-month evaluation.1
Therapy Clinical Summary, 2003.
Medtronic data on file.
This website is intended to be educational and is not to be used as a diagnostic tool. It is not intended to replace the information provided to you by your healthcare providers and does not constitute medical advice. The information may not be directly applicable for your individual clinical circumstance. Please talk with your doctor about diagnosis and treatment information.
This information is designed to provide you with helpful educational information but is for information purposes only, is not medical advice, and should not be used as an alternative to speaking with your doctor. No representation is made that the information provided is current, complete, or accurate. Medtronic does not assume any responsibility for persons relying on the information provided. Be sure to discuss questions specific to your health and treatments with a healthcare professional. For more information please speak to your healthcare professional.